Bone Health

Teriparatide

Teriparatide (Forteo)

Recombinant PTH (1-34). FDA-approved for osteoporosis. Anabolic bone agent.

Typical dose

20–20 mcg

Frequency

Daily

Half-life

—

Route

subcutaneous

Typical vial sizes

2.4 mg

Sample reconstitution

2.4 mg vial · 2 mL bac water · 20 mcg dose

Draw volume: 0.017 mL
Insulin units: 2 units
Concentration: 1.20 mg/mL
Doses per vial: 120.0

Open full calculator →

Research notes

FDA-approved. 2-year max treatment duration.

Research use only.

Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.